VNOTES – Our Latest Paper, is now online free!

The Marchand Institute’s latest publication, “Systematic review and meta-analysis of vaginal natural orifice transluminal endoscopic surgery vs laparoscopic hysterectomy” has just been posted in Pubmed today, and the full text is available online for free.  You can see the full text either at Pubmed Central at this link, or at Elsevier’s website for the journal…

Major Marchand Institute Study in Green Journal Today

The Marchand Institute’s major study entitled “Vaginal Hysterectomy Compared With Laparoscopic Hysterectomy in Benign Gynecologic Conditions: A Systematic Review and Meta-analysis” appears online today in the Green Journal (Obstetrics & Gynecology). This is the largest study to date comparing the advantages and safety of vaginal hysterectomy versus laparoscopic, and has some very interesting findings! Click…

New Study on Cervical Cancer, “Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer” is now available online!

The Marchand Institute for Minimally Invasive Surgery is thrilled to announce that our newest publication “Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer” is now available online. For the first 30 days, Elsevier is offering the article free of charge to anyone who wishes to…

FDA Issues Clarification on Black Box Warning on Power Morcellation Devices

In an official email to the Marchand Institute for Minimally Invasive Surgery, a major research institute in the field of minimally invasive gynecologic surgery and tissue morcellation, the FDA clarified it’s position on the “Black Box” warning currently placed on laparoscopic surgical power morcellation devices (LPM’s) in the United States. Because LPM’s have the potential…

New Marchand Institute Study Shows effect of a 20% intravenous fat emulsion therapy on IVF and ICSI

Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as IntralipidTM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or…

Newly Published Marchand Institute Analysis on mRNA Vaccination Validates Link Between mRNA Vaccines and Cardiac Mortality

Just published today in Taylor & Francis’s prestigious journal, “Human Vaccines & Immunotherapeutics,” is a groundbreaking study on the safety of COVID19 mRNA vaccines.  The study, the first of its kind on this subject, used statistical analysis to compare the risk of death and specifically the risk of death from cardiac causes (heart attacks, heart…

Largest Study Ever on COVID19 Vaccination in Pregnancy Published by Marchand Institute

The Marchand Institute for Minimally Invasive Surgery is excited to have published the largest study ever performed investigating the effects of COVID19 vaccinations in pregnancy. This study looked at the affect these vaccinations had on the health of both mother and baby, and how effective these vaccines were are preventing COVID19 infection in mothers and…

Marchand Institute’s Newest Paper on Hysteroscopy Appears this Month in AJOG: Global Reports

We are thrilled to announce that our latest paper on the value of hysteroscopy on asymptomatic patients prior to assisted reproduction technologies is the first paper in this quarter’s edition of AJOG: Global Reports. The full article is available online at this link: https://www.sciencedirect.com/science/article/pii/S2666577823000199?via%3Dihub